Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Methylpyridine >  5-FORMYL-2-METHOXY-4-PICOLINE

5-FORMYL-2-METHOXY-4-PICOLINE

Basic information Safety Supplier Related

5-FORMYL-2-METHOXY-4-PICOLINE Basic information

Product Name:
5-FORMYL-2-METHOXY-4-PICOLINE
Synonyms:
  • 5-FORMYL-2-METHOXY-4-PICOLINE
  • 3-Pyridinecarboxaldehyde, 6-methoxy-4-methyl- (9CI)
  • 6-methoxy-4-methylnicotinaldehyde
  • 6-Methoxy-4-methyl-3-pyridinecarboxaldehyde
  • CML-015
  • 3-Pyridinecarboxaldehyde, 6-methoxy-4-methyl-
  • 2-Fluoro-37-(methylthio)pyridine
CAS:
123506-66-1
MF:
C8H9NO2
MW:
151.16
Product Categories:
  • ALDEHYDE
  • Pyridine
Mol File:
123506-66-1.mol
More
Less

5-FORMYL-2-METHOXY-4-PICOLINE Chemical Properties

Melting point:
91-92 °C(Solv: hexane (110-54-3))
Boiling point:
274.2±35.0 °C(Predicted)
Density 
1.123±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
2.25±0.18(Predicted)
Appearance
White to off-white Solid
More
Less

5-FORMYL-2-METHOXY-4-PICOLINE Usage And Synthesis

Synthesis

68-12-2

164513-39-7

123506-66-1

General procedure for the synthesis of 5-formyl-2-methoxy-4-methyl-4-methylpyridine from 2-methoxy-4-methyl-5-bromopyridine and N,N-dimethylformamide: 5-bromo-2-methoxy-4-methylpyridine (2.6 g, 13 mmol) was dissolved in anhydrous THF (40 mL) and cooled to -70 °C under argon protection. A hexane solution of 1.6 M n-butyllithium (8.1 mL, 14 mmol) was slowly added over 10 min with stirring. The reaction temperature was maintained at -70 °C and stirring was continued for 30 min. Subsequently, anhydrous DMF (1.2 mL, 15 mmol) was added in batches, keeping the temperature constant. After addition, stirring was continued at -70 °C for 30 min, then brought to room temperature and stirred overnight. Upon completion of the reaction, the reaction was quenched with 1 M hydrochloric acid (40 mL) and subsequently extracted three times with tert-butyl methyl ether (TBME). The organic phases were combined, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated. Purification by column chromatography using tert-butyl methyl ether-light petroleum ether (1:1) as eluent afforded 1.8 g (91% yield) of 5-formyl-2-methoxy-4-methylpyridine as a light yellow solid.LC-MS m/z 152 (M + 1); 1H NMR (CDCl3) δ 10.1 (s, 1H), 8.55 (s, 1H), 6.61 ( s, 1H), 4.05 (s, 3H), 2.60 (s, 3H) ppm.

References

[1] Patent: WO2006/65215, 2006, A1. Location in patent: Page/Page column 19; 35
[2] Synthetic Communications, 2009, vol. 39, # 17, p. 3060 - 3068
[3] Patent: WO2015/158427, 2015, A1. Location in patent: Page/Page column 84; 85

5-FORMYL-2-METHOXY-4-PICOLINESupplier

Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
SynAsst Chemical.
Tel
021-60343070
Anichem Inc.
Tel
0512-69369885
Email
sales@anichem.com.cn
Shanghai Hong-chuang Pharma Tech Co., Ltd.
Tel
18151128828
Email
hc-sales@foxmail.com
Porse Fine Chemical Co.,LTD
Tel
20-66003216 18666003216
Email
info@porsefinechemical.com